Concepedia

Paul DeLucca

PD

Statistics

Publications

22

Citations

5.1K

H-Index

21

Active since

1997

Affiliations

Brigham and Women's Hospital(Current)

United States Military Academy

Merck & Co., Inc., Rahway, NJ, USA (United States)

Duke Medical Center

University of Brescia

Paul DeLucca is an author at Brigham and Women's Hospital specializing in medicine, pharmacology, and cardiovascular pharmacotherapy.

Publications per year

1997–2021

22

Publications

22

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

Christopher P. Cannon, William S. Weintraub, Laura A. Demopoulos et al. · New England Journal of Medicine · 2001 · 2.1K citations · Full text

Medicine, Cardiology, Internal Medicine +16

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization

Eric J. Topol, David J. Moliterno, Howard C. Herrmann et al. · New England Journal of Medicine · 2001 · 681 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Rolofylline, an Adenosine A<sub>1</sub>−Receptor Antagonist, in Acute Heart Failure

Barry M. Massie, Christopher M. O’Connor, Marco Metra et al. · New England Journal of Medicine · 2010 · 507 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non–ST-Segment Elevation Acute Coronary Syndromes

Richard G. Bach, Christopher P. Cannon, William S. Weintraub et al. · Annals of Internal Medicine · 2004 · 381 citations

Medicine, Cardiology, Internal Medicine +17

Oral Montelukast Compared with Inhaled Salmeterol To Prevent Exercise-Induced Bronchoconstriction

Jonathan M. Edelman, Jennifer Turpin, Edwin A. Bronsky et al. · Annals of Internal Medicine · 2000 · 215 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

1–5 of 22